Serum from fulminant hepatic failure patients impairs C3A cell metabolism through inhibition of mitochondrial function.

C Filippi, N Johnstone, PN Newsome, PC Hayes, JN Plevris

Research output: Contribution to journalMeeting abstractpeer-review

Original languageEnglish
Pages (from-to)171A-171A
Number of pages1
Issue number4
Publication statusPublished - Oct 2002
Event53rd Annual Meeting of the Association-for-the-Study-of-Liver-Diseases (AASLD) - BOSTON, United Kingdom
Duration: 1 Nov 20025 Nov 2002

Cite this